CHEONGJU, South Korea, September 17, 2025--(BUSINESS WIRE)--Celltrion Pharm (KOSDAQ: 068706), a South Korean biopharmaceutical firm, said on September 16 that it has inked a strategic trilateral ...
On May 22, Celltrion Pharm held a tour of its Cheongju plant's PFS (pre-filled syringe) production facility in Ochang-eup, Chungcheongbuk-do, for pharmaceutical and bio analysts from domestic ...
Strengthen the PFS CMO business through a long-term partnership with global syringe leader BD Expand the global customer network by leveraging the BD&CMO Partnership Program Triple production capacity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback